Early diagnosis, targeted therapeutics, and more personalized multimodal treatments have boosted survival rates of patients with cancer and have led to a large and rapidly increasing number of cancer survivors. This is particularly true for patients with Hodgkin's lymphoma, where successive trials have registered continuous progress in the development of treatment strategies for this disease.

Source: Late effects of treatment study continues sustained academic effort in Hodgkin's lymphoma